IRIS
Stefanini, Giulio Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.561
AS - Asia 6.924
EU - Europa 2.188
SA - Sud America 1.555
Continente sconosciuto - Info sul continente non disponibili 499
AF - Africa 295
OC - Oceania 17
Totale 24.039
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.232
SG - Singapore 4.245
BR - Brasile 1.295
CN - Cina 1.185
VN - Vietnam 652
IT - Italia 497
FI - Finlandia 375
IE - Irlanda 277
DE - Germania 218
HK - Hong Kong 180
NG - Nigeria 177
IN - India 171
GB - Regno Unito 159
CA - Canada 158
FR - Francia 145
SE - Svezia 119
AR - Argentina 104
NL - Olanda 104
BD - Bangladesh 79
MX - Messico 66
RU - Federazione Russa 58
TR - Turchia 53
IQ - Iraq 50
ID - Indonesia 44
EC - Ecuador 42
JP - Giappone 38
PL - Polonia 37
ES - Italia 36
UA - Ucraina 29
ZA - Sudafrica 29
VE - Venezuela 28
CR - Costa Rica 24
MA - Marocco 23
CO - Colombia 22
SA - Arabia Saudita 22
BE - Belgio 21
PK - Pakistan 20
PH - Filippine 19
IL - Israele 18
JM - Giamaica 18
PE - Perù 18
CL - Cile 17
MY - Malesia 17
PY - Paraguay 16
UZ - Uzbekistan 15
DZ - Algeria 14
AZ - Azerbaigian 13
GR - Grecia 13
AE - Emirati Arabi Uniti 12
KE - Kenya 12
AU - Australia 11
JO - Giordania 11
LT - Lituania 11
AT - Austria 10
EG - Egitto 10
PT - Portogallo 10
CZ - Repubblica Ceca 9
HN - Honduras 9
TT - Trinidad e Tobago 9
UY - Uruguay 9
GT - Guatemala 8
NP - Nepal 8
RO - Romania 8
KZ - Kazakistan 7
TH - Thailandia 7
TW - Taiwan 7
CH - Svizzera 6
NI - Nicaragua 6
OM - Oman 6
PA - Panama 6
SN - Senegal 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
KR - Corea 5
KW - Kuwait 5
LB - Libano 5
TN - Tunisia 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
BS - Bahamas 4
DO - Repubblica Dominicana 4
EE - Estonia 4
IR - Iran 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
BG - Bulgaria 3
CU - Cuba 3
DK - Danimarca 3
ET - Etiopia 3
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NO - Norvegia 3
PR - Porto Rico 3
Totale 23.500
Salva come PNG Salva come JPEG
Città #
Singapore 1.938
Ashburn 1.018
San Jose 1.001
Chandler 981
Wilmington 964
The Dalles 608
Dallas 584
Shanghai 526
Council Bluffs 481
San Mateo 417
Helsinki 373
Beijing 300
New York 285
Boardman 272
Dublin 271
Ho Chi Minh City 236
Ann Arbor 228
Princeton 197
Lawrence 181
Santa Clara 178
Benin City 177
Los Angeles 176
Milan 170
Hanoi 167
Hong Kong 162
Leawood 147
São Paulo 118
Woodbridge 100
Paris 95
Phoenix 94
Fairfield 91
Amsterdam 86
Rome 74
Chicago 65
Pune 57
Seattle 57
Buffalo 55
London 42
San Diego 38
Montreal 37
Munich 36
Falkenstein 34
Toronto 34
Warsaw 34
Brooklyn 33
Brasília 32
Orem 30
Rio de Janeiro 30
Tokyo 30
Atlanta 29
Belo Horizonte 28
Houston 28
Charlotte 27
Da Nang 27
San Francisco 27
Curitiba 26
Chennai 25
Norwalk 25
Kocaeli 24
Mexico City 24
Columbus 22
The Bronx 21
Boston 20
Brussels 20
Haiphong 20
Stockholm 20
Baghdad 19
Denver 19
Philadelphia 19
Cleveland 18
Frankfurt am Main 18
Naples 18
Queens 18
San José 18
Cologno Monzese 17
Miami 17
Reston 17
Richmond 17
Campinas 16
Dhaka 16
Ribeirão Preto 16
Guarulhos 15
Indianapolis 15
Las Vegas 15
Long Beach 15
Quito 15
Assago 14
Guayaquil 14
Kingston 14
San Antonio 13
Abbeville 12
Fortaleza 12
Johannesburg 12
Louisville 12
Manchester 12
Moscow 12
Pittsburgh 12
Porto Alegre 12
Redmond 12
Baku 11
Totale 14.265
Salva come PNG Salva come JPEG
Nome #
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 160
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 153
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 139
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 128
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention. 126
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 123
2014 ESC/EACTS Guidelines on myocardial revascularization 122
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients 120
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 119
CAD in TAVI patients: relevance of disease complexity 118
Does clinical data quality affect fluid-structure interaction simulations of patient-specific stenotic aortic valve models? 118
2014 ESC/EACTS Guidelines on myocardial revascularization. 117
4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New Generation Drug-Eluting Stents in the RESOLUTE All Comers Randomized Trial. 116
2018 ESC/EACTS Guidelines on myocardial revascularization. 116
2018 ESC/EACTS Guidelines on myocardial revascularization 116
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 115
2014 ESC/EACTS Guidelines on myocardial revascularization 114
Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. 114
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 114
How should I treat a DES restenosis in a graft anastomosis with challenging access and multiple previous coronary interventions? 112
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. 112
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 110
[Advances in the treatment of complex atherosclerotic disease: cracking the calcium and beyond] 108
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 108
Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation 107
2018 ESC/EACTS Guidelines on myocardial revascularization 107
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. 107
What constitutes sufficient clinical evidence for stents? SpotLITE on the evaluation of novel coronary devices. 105
A new device for vascular embolization: report on case of two pulmonary arteriovenous fistulas embolization using the amplatzer vascular plug 105
[SICI-GISE/SICOA Consensus document: Clinical follow-up of patients after acute coronary syndrome or percutaneous coronary intervention] 104
On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid–Structure Interaction Approach 103
Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group 103
[Towards a standardized and minimalist future in interventional cardiology] 101
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis 100
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 99
An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study 99
Clinical outcomes of bioresorbable versus durable polymer-coated everolimus-eluting stents in real-world complex patients. 98
An update on drug-eluting stents versus bare-metal stents in PCI treatment: are there any remaining indications for BMS use? 98
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials. 98
Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score 96
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 96
Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis 95
Aspiration Thrombectomy for Treatment of ST-segment Elevation Myocardial Infarction: a Meta-analysis of 26 Randomized Trials in 11 943 Patients 95
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 94
Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties 93
Efficacy and Safety of Calcium Channel Blocker/Diuretics Combination Therapy in Hypertensive Patients: A Meta-Analysis. 93
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 93
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 93
Coronary stents: novel developments 92
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. 92
Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom (TM) drug-coated stent vs. the Gazelle (TM) bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy 92
Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review 92
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 92
The synergy stent in high-bleeding risk patients: why design matters 91
Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality 91
Another reason to endorse and spread guidelines 91
Coronary Artery Disease Severity and Aortic Stenosis: Clinical Outcomes According to SYNTAX-Score in Patients Undergoing Transcatheter Aortic Valve Implantation 91
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 91
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study 90
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 90
New approach to direct stenting using a novel 'All-In-One' coronary stent system via 5 french diagnostic catheters: A pilot study 89
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 87
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 87
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 87
Characterization of Myocardial Injury in Patients With COVID-19 87
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 86
Impact of Right Ventricular Pacing in Patients With TAVR Undergoing Permanent Pacemaker Implantation 86
What's new in the 2018 ESC/EACTS guidelines on myocardial revascularization? 86
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 86
Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes 85
Safety and Efficacy of Resolute Zotarolimus-Eluting Stents Compared With Everolimus-Eluting Stents A Meta-Analysis 85
Surgical or percutaneous revascularization for isolated left anterior descending stenoses: are we in the same boat? 85
Can Coronary Computed Tomography Angiography Replace Invasive Angiography? Coronary Computed Tomography Angiography Cannot Replace Invasive Angiography 85
Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. 84
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience. 84
Stent performance: never too late to sort it out. 84
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study. 84
[Cardiac biomarkers in patients with COVID-19: pragmatic tools in hard times] 83
Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials. 83
Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 83
Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention: A Meta-Analysis of Randomized Trials 82
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention Results of a Nonrandomized Observational Study 82
Management of ST-elevation myocardial infarction according to European and American guidelines. 82
State of the art: coronary artery stents - past, present and future. 82
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis 82
Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial 82
P2Y12 vs. aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and Meta-analysis 81
The Valsalva maneuver in the diagnosis of patent foramen ovale. 81
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 81
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering 80
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 80
Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry 80
Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques. 80
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design 80
Cardiovascular safety of assisted reproductive technology: a meta-analysis 79
Long-term prognostic impact of subclinical myocardial dysfunction in patients recovered from COVID-19 79
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention. 79
Are the culprit lesions severely stenotic? 79
Severe aortic stenosis and coronary artery disease. 79
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 79
Totale 9.690
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.480
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022853 0 0 0 245 6 2 21 148 73 68 246 44
2022/20232.885 421 110 236 313 315 206 13 213 514 287 197 60
2023/20242.132 222 151 406 128 105 275 153 128 20 49 196 299
2024/20253.368 45 32 43 32 60 351 281 330 478 837 416 463
2025/20269.092 1.377 683 500 871 313 460 2.541 473 465 581 314 514
2026/20273.844 527 732 2.163 422 0 0 0 0 0 0 0 0
Totale 24.039